JP2023527364A5 - - Google Patents
Info
- Publication number
- JP2023527364A5 JP2023527364A5 JP2022572585A JP2022572585A JP2023527364A5 JP 2023527364 A5 JP2023527364 A5 JP 2023527364A5 JP 2022572585 A JP2022572585 A JP 2022572585A JP 2022572585 A JP2022572585 A JP 2022572585A JP 2023527364 A5 JP2023527364 A5 JP 2023527364A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- enpp1
- enpp3
- agent
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030840P | 2020-05-27 | 2020-05-27 | |
| US63/030,840 | 2020-05-27 | ||
| PCT/US2021/034533 WO2021243031A1 (en) | 2020-05-27 | 2021-05-27 | Compositions and methods for treating peripheral artery disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527364A JP2023527364A (ja) | 2023-06-28 |
| JP2023527364A5 true JP2023527364A5 (https=) | 2024-06-04 |
Family
ID=78722768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572585A Pending JP2023527364A (ja) | 2020-05-27 | 2021-05-27 | 末梢動脈疾患を治療するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230372455A1 (https=) |
| EP (1) | EP4157329A4 (https=) |
| JP (1) | JP2023527364A (https=) |
| KR (1) | KR20230048480A (https=) |
| CN (1) | CN116406281A (https=) |
| AU (1) | AU2021282350A1 (https=) |
| BR (1) | BR112022024143A2 (https=) |
| CA (1) | CA3179982A1 (https=) |
| CO (1) | CO2022018399A2 (https=) |
| IL (1) | IL298484A (https=) |
| MX (1) | MX2022014717A (https=) |
| TW (1) | TW202212570A (https=) |
| WO (1) | WO2021243031A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023549738A (ja) | 2020-10-30 | 2023-11-29 | １シーバイオ， インコーポレイテッド | エクトヌクレオチドピロホスファターゼ－ホスホジエステラーゼ－１（ｅｎｐｐ１）阻害物質及びそれらの使用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10926006B2 (en) * | 2015-02-26 | 2021-02-23 | Remodeless Cv Ltd | Drug eluting stent |
| EP4414028A3 (en) * | 2015-05-19 | 2024-11-27 | Yale University | Compositions for treating pathological calcification conditions, and methods using same |
| EP3471747A1 (en) * | 2016-06-16 | 2019-04-24 | Alexion Pharmaceuticals, Inc. | Methods of treating myointimal proliferation |
| US12134790B2 (en) * | 2017-09-27 | 2024-11-05 | Inozyme Pharma, Inc. | Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1) |
| AU2019267545A1 (en) * | 2018-05-08 | 2020-11-26 | Yale University | Compositions and methods for reducing progression of nephrolithiasis |
-
2021
- 2021-05-27 KR KR1020227045747A patent/KR20230048480A/ko active Pending
- 2021-05-27 MX MX2022014717A patent/MX2022014717A/es unknown
- 2021-05-27 EP EP21812898.1A patent/EP4157329A4/en active Pending
- 2021-05-27 CA CA3179982A patent/CA3179982A1/en active Pending
- 2021-05-27 AU AU2021282350A patent/AU2021282350A1/en active Pending
- 2021-05-27 BR BR112022024143A patent/BR112022024143A2/pt unknown
- 2021-05-27 CN CN202180061245.3A patent/CN116406281A/zh active Pending
- 2021-05-27 IL IL298484A patent/IL298484A/en unknown
- 2021-05-27 JP JP2022572585A patent/JP2023527364A/ja active Pending
- 2021-05-27 WO PCT/US2021/034533 patent/WO2021243031A1/en not_active Ceased
- 2021-05-27 TW TW110119288A patent/TW202212570A/zh unknown
-
2022
- 2022-11-23 US US18/058,715 patent/US20230372455A1/en active Pending
- 2022-12-19 CO CONC2022/0018399A patent/CO2022018399A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mattson et al. | Neural nitric oxide synthase in the renal medulla and blood pressure regulation | |
| US5730975A (en) | Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function | |
| Rubattu et al. | Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases | |
| Lopez et al. | Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia | |
| RU2311910C2 (ru) | Ингибирование stat-1 | |
| Hopkins et al. | Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia | |
| Lucerna et al. | Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment | |
| JP2023527365A5 (https=) | ||
| JPH09509324A (ja) | 増殖阻止ホメオボックス遺伝子 | |
| JPS6256440A (ja) | 不要細胞の分解あるいは阻止物質からなる治療剤 | |
| JP2023527364A5 (https=) | ||
| WO2012167261A2 (en) | Compositions and methods for treating and preventing neointimal stenosis | |
| Liu et al. | The pathogenesis and impact of arterial stiffening in hypertension: the 2023 John H. Laragh research award | |
| JP2005507920A (ja) | Ｔｏｌｌ様レセプター４を阻害することによる脈管疾患の処置 | |
| EP1737490B1 (en) | Methods of treating atherosclerosis | |
| JP2023532732A5 (https=) | ||
| US8372421B2 (en) | Inhibition of mitogen-activated protein kinases in cardiovascular disease | |
| WO2021067952A1 (en) | Targeted nanomedicine for treating vascular disorders | |
| JP2005505283A (ja) | Ｓｔａｔ−１依存的遺伝子の発現の調節 | |
| Lien et al. | Gene therapy for renal disorders: what are the benefits for the elderly? | |
| EP3826637A1 (en) | Treatment of vascular occlusion by activation of notch signaling | |
| CN106621003A (zh) | 一种药物球囊导管及其制备方法和应用 | |
| WO2006112597A1 (en) | A stent coated with anti-integrin antibody and process for preparing the same | |
| WO2007043629A1 (ja) | エフリンｂ２を用いる血管新生の抑制方法 | |
| Kraaijeveld et al. | BCL6 inhibition: a promising approach to prevent germinal center-driven allo-immune responses |